CS-1008

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for CS-1008, covering 2007-09-11 to 2020-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer [Phase 2]